Intellia Therapeutics (NTLA) PT Lowered to $74 at JPMorgan

October 2, 2023 8:42 AM EDT Send to a Friend

JPMorgan analyst Brian Cheng lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Intellia Therapeutics (NTLA) PT Lowered to $74 at JPMorgan

Member Login

Free News Feed